Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease

Circulation. 2011 May 24;123(20):2263-73. doi: 10.1161/CIRCULATIONAHA.110.981738.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / metabolism
  • Enzyme Inhibitors / therapeutic use*
  • Guanylate Cyclase / antagonists & inhibitors*
  • Guanylate Cyclase / metabolism
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / metabolism
  • Receptors, Cytoplasmic and Nuclear / antagonists & inhibitors*
  • Receptors, Cytoplasmic and Nuclear / metabolism
  • Signal Transduction / drug effects*
  • Signal Transduction / physiology
  • Soluble Guanylyl Cyclase

Substances

  • Enzyme Inhibitors
  • Receptors, Cytoplasmic and Nuclear
  • Guanylate Cyclase
  • Soluble Guanylyl Cyclase